Replimune Group Inc
For the period ended Mar 31, 2024. Filed May 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed May 16, 2024
REPL$23.28+4.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated statements of stockholders’ equity F-
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Amounts in thousands, except share amounts)
| Common stock · Additional paid-in capital · Accumulated deficit · Accumulated other comprehensive income (loss) · Total stockholders’ equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Amount | ||||||
| Balances as of March 31, 2022 | 47,338,660 | $47 | $723,359 | $(311,204) | $(973) | $411,229 |
| Issuance of common stock through ATM sales, net of offering costs | 2,026,438 | 2 | 37,436 | — | — | 37,438 |
| Issuance of prefunded warrants to purchase common stock | — | — | 92,778 | — | — | 92,778 |
| Issuance of common stock, net of issuance costs and underwriter fees | 6,810,658 | 7 | 149,847 | — | — | 149,854 |
| Foreign currency translation adjustment | — | — | — | — | 5,483 | 5,483 |
| Unrealized gain on short-term investments | — | — | — | — | 1,219 | 1,219 |
| Exercise of stock options | 296,876 | 1 | 3,443 | — | — | 3,444 |
| Vesting of RSUs | 203,681 | — | — | — | — | — |
| Stock-based compensation expense | — | — | 28,131 | — | — | 28,131 |
| Net loss | — | — | — | (174,284) | — | (174,284) |
| Balances as of March 31, 2023 | 56,676,313 | $57 | $1,034,994 | $(485,488) | $5,729 | $555,292 |
| Foreign currency translation adjustment | — | — | — | — | (826) | (826) |
| Unrealized loss on short-term investments | — | — | — | — | (48) | (48) |
| Exercise of pre-funded warrants | 4,202,622 | 4 | (4) | — | — | — |
| Exercise of stock options | 164,221 | — | 1,759 | — | — | 1,759 |
| Vesting of RSUs | 371,949 | — | — | — | — | — |
| Stock-based compensation expense | — | — | 34,125 | — | — | 34,125 |
| Net loss | — | — | — | (215,794) | — | (215,794) |
| Balances as of March 31, 2024 | 61,415,105 | $61 | $1,070,874 | $(701,282) | $4,855 | $374,508 |
F - 7
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.